These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [The relation between morphologic and functional airway changes in bronchial asthma]. Kips JC Verh K Acad Geneeskd Belg; 2003; 65(4):247-65; discussion 265-9. PubMed ID: 14534940 [TBL] [Abstract][Full Text] [Related]
24. Pathogenesis of airway inflammation in bronchial asthma. Nakagome K; Nagata M Auris Nasus Larynx; 2011 Oct; 38(5):555-63. PubMed ID: 21334836 [TBL] [Abstract][Full Text] [Related]
25. The etiologies, pathophysiology, and alternative/complementary treatment of asthma. Miller AL Altern Med Rev; 2001 Feb; 6(1):20-47. PubMed ID: 11207455 [TBL] [Abstract][Full Text] [Related]
26. The effect of a single inhaled dose of a VLA-4 antagonist on allergen-induced airway responses and airway inflammation in patients with asthma. Ravensberg AJ; Luijk B; Westers P; Hiemstra PS; Sterk PJ; Lammers JW; Rabe KF Allergy; 2006 Sep; 61(9):1097-103. PubMed ID: 16918513 [TBL] [Abstract][Full Text] [Related]
27. Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity. Matsuse H; Kong X; Hu J; Wolf SF; Lockey RF; Mohapatra SS Int Immunopharmacol; 2003 Apr; 3(4):457-68. PubMed ID: 12689651 [TBL] [Abstract][Full Text] [Related]
28. Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3K Allen RA; Brookings DC; Powell MJ; Delgado J; Shuttleworth LK; Merriman M; Fahy IJ; Tewari R; Silva JP; Healy LJ; Davies GCG; Twomey B; Cutler RM; Kotian A; Crosby A; McCluskey G; Watt GF; Payne A J Pharmacol Exp Ther; 2017 Jun; 361(3):429-440. PubMed ID: 28442583 [TBL] [Abstract][Full Text] [Related]
29. Role of the phosphoinositide 3-kinase p110delta in generation of type 2 cytokine responses and allergic airway inflammation. Nashed BF; Zhang T; Al-Alwan M; Srinivasan G; Halayko AJ; Okkenhaug K; Vanhaesebroeck B; Hayglass KT; Marshall AJ Eur J Immunol; 2007 Feb; 37(2):416-24. PubMed ID: 17236236 [TBL] [Abstract][Full Text] [Related]
30. Targeting T cells for asthma. Heijink IH; Van Oosterhout AJ Curr Opin Pharmacol; 2005 Jun; 5(3):227-31. PubMed ID: 15907907 [TBL] [Abstract][Full Text] [Related]
31. Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma. Herbert C; Hettiaratchi A; Webb DC; Thomas PS; Foster PS; Kumar RK Clin Exp Allergy; 2008 May; 38(5):847-56. PubMed ID: 18307529 [TBL] [Abstract][Full Text] [Related]